X

Vous n'êtes pas connecté

Maroc Maroc - MEDINDIA.NET - Latest Tropical Condition News - 08/Mar 22:53

Key Protein ARK1 Identified as New Malaria Drug Target

An international team of researchers has identified ba key protein, Aurora-related kinase 1 (ARK1), that controls cell division in the medlinkmalaria

Articles similaires

Key Protein ARK1 Identified as New Malaria Drug Target

medindia.net - 08/Mar 22:53

An international team of researchers has identified ba key protein, Aurora-related kinase 1 (ARK1), that controls cell division in the...

Key Protein ARK1 Identified as New Malaria Drug Target

medindia.net - 02/Mar 17:29

Scientists find ARK1 protein vital for malaria parasite division; disabling it halts replication and transmission, offering a promising new drug...

New protein target for safer lung cancer therapy

news.medical.net - 12/Mar 05:06

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The...

Sorry! Image not available at this time

Blocking a common brain gas reverses autism-like traits in mice

wn.com - 07/Mar 19:58

A newly discovered biological chain reaction explains how high levels of a common brain chemical can lead to cellular overdrive in autism spectrum...

Sorry! Image not available at this time

Blocking a common brain gas reverses autism-like traits in mice

wn.com - 07/Mar 19:58

A newly discovered biological chain reaction explains how high levels of a common brain chemical can lead to cellular overdrive in autism spectrum...

Sorry! Image not available at this time

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

wn.com - 28/Feb 18:44

This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase inhibitor, the first for...

Sorry! Image not available at this time

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

wn.com - 28/Feb 18:44

This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase inhibitor, the first for...

Aggressive oral cancer can be identified at an early stage by changes in lymphatic vessels

oncologynews.com.au - 27/Feb 23:42

Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumour. Finnish researchers...

Sorry! Image not available at this time

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis

wn.com - 07/Mar 06:29

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3...

Sorry! Image not available at this time

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis

wn.com - 07/Mar 06:29

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3...